Parallel Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.2K | Buy |
538
+31
| +6% | +$1.51K | ﹤0.01% | 2051 |
|
|
2025
Q1 | $17.2K | Buy |
507
+67
| +15% | +$2.28K | ﹤0.01% | 2199 |
|
|
2024
Q4 | $17.3K | Hold |
440
| – | – | ﹤0.01% | 2182 |
|
|
2024
Q3 | $20.7K | Sell |
440
-399
| -48% | -$18.8K | ﹤0.01% | 2064 |
|
|
2024
Q2 | $45.3K | Buy |
839
+96
| +13% | +$5.18K | ﹤0.01% | 1572 |
|
|
2024
Q1 | $50.6K | Buy |
743
+391
| +111% | +$26.6K | ﹤0.01% | 1491 |
|
|
2023
Q4 | $22K | Buy |
352
+139
| +65% | +$8.7K | ﹤0.01% | 1874 |
|
|
2023
Q3 | $9.67K | Buy |
213
+20
| +10% | +$908 | ﹤0.01% | 2217 |
|
|
2023
Q2 | $10.8K | Hold |
193
| – | – | ﹤0.01% | 2138 |
|
|
2023
Q1 | $8.73K | Sell |
193
-47
| -20% | -$2.13K | ﹤0.01% | 2193 |
|
|
2022
Q4 | $9.76K | Sell |
240
-74
| -24% | -$3.01K | ﹤0.01% | 2034 |
|
|
2022
Q3 | $21K | Sell |
314
-3
| -0.9% | -$201 | ﹤0.01% | 1644 |
|
|
2022
Q2 | $19K | Buy |
317
+13
| +4% | +$779 | ﹤0.01% | 1673 |
|
|
2022
Q1 | $19K | Sell |
304
-100
| -25% | -$6.25K | ﹤0.01% | 1729 |
|
|
2021
Q4 | $31K | Buy |
404
+74
| +22% | +$5.68K | ﹤0.01% | 1564 |
|
|
2021
Q3 | $37K | Sell |
330
-103
| -24% | -$11.5K | ﹤0.01% | 1399 |
|
|
2021
Q2 | $70K | Buy |
433
+125
| +41% | +$20.2K | ﹤0.01% | 1061 |
|
|
2021
Q1 | $38K | Buy |
308
+63
| +26% | +$7.77K | ﹤0.01% | 1286 |
|
|
2020
Q4 | $38K | Buy |
+245
| New | +$38K | ﹤0.01% | 1199 |
|
|
2020
Q2 | – | Sell |
-557
| Closed | -$23K | – | 2474 |
|
|
2020
Q1 | $23K | Buy |
557
+198
| +55% | +$8.18K | ﹤0.01% | 1244 |
|
|
2019
Q4 | $22K | Hold |
359
| – | – | ﹤0.01% | 1347 |
|
|
2019
Q3 | $15K | Hold |
359
| – | – | ﹤0.01% | 1478 |
|
|
2019
Q2 | $17K | Buy |
+359
| New | +$17K | ﹤0.01% | 1342 |
|
|
2018
Q3 | – | Sell |
-200
| Closed | -$11K | – | 2228 |
|
|
2018
Q2 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 1293 |
|